ReviewJournal of hepatology2023

Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference.

Marc G Ghany et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.